Loading interface...

Lipigo F (5/160 mg) Tablet

Manufactured byMerck India Ltd.
ContainsRosuvastatin (5 mg) + Fenofibrate (160 mg)
Description
Lipigo F (5/160 mg) Tablet is a combination medicine that consists of Rosuvastatin and Fenofibrate. It is used in the treatment of high blood cholesterol and triglycerides (fats) levels. This medicine works by blocking the production of unhealthy fats in your body and prevents the risk of heart problems and stroke (a condition that causes reduced oxygen supply to the brain). Lipigo F (5/160 mg) Tablet has some side effects like headache, nausea, weakness, muscle pain, and stomach pain. These side effects are mild and may subside by themselves. Consult your doctor if these side effects last for a long time or become severe. Avoid consuming alcohol while taking this medicine as it may cause liver damage. Avoid taking this medicine if you are allergic to it. Lipigo F (5/160 mg) Tablet can be taken with or without food. Take the dose as prescribed by your doctor. Take it regularly at the same time for the ease of remembering. Never take more than the prescribed dose. Do not stop taking this medicine without consulting your doctor as it may increase the lipid (fat) levels in your body. Lipigo F (5/160 mg) Tablet is not recommended for use if you have severe kidney problems, pre-existing liver conditions, or gallbladder conditions such as gallstones (solid deposits that develop in your gallbladder). Use this medicine with caution if you have diabetes or hypothyroidism (low levels of thyroid hormone in the body). Lipigo F (5/160 mg) Tablet is not recommended for use in children below 18 years of age. Consult your doctor if you are pregnant, planning a pregnancy, or are breastfeeding before taking this medicine.

Side effects

Major & minor side effects for Lipigo F (5/160 mg) Tablet

  • Muscle pain
  • Tenderness
  • Weakness
  • Joint pain
  • Acid or sour stomach
  • Diarrhoea
  • Excessive air or gas in stomach
  • Blood in urine
  • Redness of the skin especially on the face and neck
  • Chills and fever
  • Itching and skin rash
  • Nausea and vomiting
  • Headache
  • Shortness of breath
  • Runny Nose

Uses of Lipigo F (5/160 mg) Tablet

What is it prescribed for?

  • Hyperlipidemia
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    Lipigo F (5/160 mg) Tablet starts showing its effects within 4-5 hours of intake.
  • How long do the effects of this medicine last?
    The duration for which Lipigo F (5/160 mg) Tablet remains active in your body is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with Lipigo F (5/160 mg) Tablet as it may lead to liver damage and other undesired effects.
  • Is this a habit forming medicine?
    No habit-forming tendency has been reported for Lipigo F (5/160 mg) Tablet.
  • Can this medicine be taken during pregnancy?
    Lipigo F (5/160 mg) Tablet is not recommended for use in pregnancy as it may harm your foetus. Consult your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    Lipigo F (5/160 mg) Tablet is not recommended for use in breastfeeding as this medicine passes into breastmilk and may harm your infant. HenceConsult your doctor before taking this medicine.

Allergy

Avoid taking Lipigo F (5/160 mg) Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms of allergic reactions such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.

Liver disease

Lipigo F (5/160 mg) Tablet may cause abnormal liver function, swelling of the liver, and liver damage. Hence, this medicine is not recommended for use if you have pre-existing liver problems as it may further worsen your condition.

Severe kidney disease

Lipigo F (5/160 mg) Tablet is not recommended for use if you have severe kidney problems. This medicine is exerted through urine and improper kidney function may lead to its accumulation. It may further lead to rhabdomyolysis (leakage of muscle contents into the blood circulation) and severe hyperkalemia (high level of potassium in your blood).

Gallbladder disease

Lipigo F (5/160 mg) Tablet is not recommended for use if you have any conditions affecting your gallbladder such as gallstones (solid deposits that develop in your gallbladder, a small pouch that stores bile produced by the liver). This medicine may further increase the risk of gallstones due to increased excretion of cholesterol into the bile (a fluid produced in the liver that helps in digestion).
Warnings for special population

Pregnancy

Lipigo F (5/160 mg) Tablet is not recommended for use in pregnancy as it may harm your foetus. Consult your doctor before taking this medicine.

Breast-feeding

Lipigo F (5/160 mg) Tablet is not recommended for use in breastfeeding as this medicine passes into breastmilk and may harm your infant. HenceConsult your doctor before taking this medicine.
General warnings

Cognitive impairment

Lipigo F (5/160 mg) Tablet may cause forgetfulness, memory loss, confusion, etc. These side effects are reversible and usually disappear once the medicine is discontinued.

Use in children

Lipigo F (5/160 mg) Tablet is not recommended for use in children under 18 years of age as the safety and efficacy data are not available.

Cholelithiasis

Cholelithiasis is a condition of the formation of stones in the gallbladder a small organ under your liver. Use Lipigo F (5/160 mg) Tablet with caution due to the increased risk of gallbladder stones. This risk is especially higher if you have a history of liver or gallbladder problems.

Hematologic changes

Lipigo F (5/160 mg) Tablet may increase the risk of a decrease in blood cell count. Your doctor may suggest tests for monitoring your complete blood count during the treatment with this medicine.

Use in elderly

Lipigo F (5/160 mg) Tablet should be used with caution in the elderly as it may increase the risk of kidney damage and serious side effects.

Missed Dose

Do not skip any dose of Lipigo F (5/160 mg) Tablet. If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not take two doses together to make up for a missed one.

Overdose

Never take more than the prescribed dose. If you suspect that you might have taken an overdose of Lipigo F (5/160 mg) Tablet, seek immediate medical attention.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with Lipigo F (5/160 mg) Tablet as it may lead to liver damage and other undesired effects.
Interaction with Medicine

Leflunomide

Atazanavir

Cyclosporine

Hypoglycemic agents

Warfarin

Disease interactions

Diabetes

Diabetes is a condition of increased blood sugar levels. Lipigo F (5/160 mg) Tablet should be used with caution if you have diabetes as this medicine may alter the blood sugar levels. Your doctor may monitor your blood sugar levels frequently while you are on treatment with this medicine.

Rhabdomyolysis

Rhabdomyolysis is a condition in which muscle tissue and proteins enter the bloodstream due to muscle injury. It may lead to kidney failure and other problems. Lipigo F (5/160 mg) Tablet should be used with caution if you have rhabdomyolysis as it may further worsen your condition. Consult your doctor immediately if you experience any unusual muscle pain, tenderness, or weakness.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Lipigo F (5/160 mg) Tablet with or without food or as instructed by your doctor. Do not crush, break or chew the tablet in your mouth. Do not stop taking Lipigo F (5/160 mg) Tablet without consulting your doctor even if you feel better after taking a few doses. Do not take more or fewer doses than prescribed. Regular exercise and a low-fat diet intake are recommended besides using this medicine for better results. Inform your doctor if you experience stomach pain, loss of appetite, a sick feeling, dark urine, muscle pain or weakness, associated with fever after taking this medicine. Avoid consuming alcohol during treatment with this medicine as it may increase the risk of side effects. Your doctor may suggest periodic blood tests to check your lipid (fat) levels and other blood components while taking this medicine. Keep the medicine away from the reach of children and pets. Ensure that the unused medicine is disposed of properly.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Lipigo F (5/160 mg) Tablet is a combination of Rosuvastatin and Fenofibrate. Rosuvastatin reduces the production of cholesterol from the liver. Fenofibrate works by increasing the natural lipid (fat) breakdown process with the help of an enzyme. This removes the bad cholesterol and triglycerides from your blood and increases the levels of good cholesterol.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Statins, Fibric acid derivatives, Antihyperlipidemic combinations

Schedule

Schedule H

Drugs, H., 2021. Rosuvastatin: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 27 September 2021].

https://medlineplus.gov/druginfo/meds/a603033.html>

Dailymed.nlm.nih.gov. 2021. DailyMed - FENOFIBRATE tablet. [online] Available at: < [Accessed 27 September 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f8f09ab1-74db-4123-b85a-6337dc2582a0>

Drugs, H., 2021. Fenofibrate: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 27 September 2021].

https://medlineplus.gov/druginfo/meds/a601052.html>

Medicines.org.uk. 2021. Crestor 5mg, 10mg, 20mg and 40mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 27 September 2021].

https://www.medicines.org.uk/emc/medicine/11976>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 19 Nov 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.